Basel Medical Group Ltd(BMGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BMGL Basel Medical Group Ltd

Trading 05-14 09:34:43 EDT

0.7468

+0.0237

+3.28%

High0.7468	Low0.7468	Vol346.00
Open0.7468	D1 Closing0.7231	Amplitude0.00%
Mkt Cap14.03M	Tradable Cap4.52M	Total Shares18.79M
T/O258.48	T/O Rate0.01%	Tradable Shares6.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BMGL","market":"US","secType":"STK","nameCN":"Basel Medical Group Ltd","latestPrice":0.7468,"timestamp":1778765402722,"preClose":0.7231,"halted":0,"volume":346,"delay":0,"changeRate":0.03277554971649849,"floatShares":6047668,"shares":18785750,"eps":-0.444619,"marketStatus":"Trading","change":0.0237,"latestTime":"05-14 09:34:43 EDT","open":0.7468,"high":0.7468,"low":0.7468,"amount":258.4847668,"amplitude":0,"askPrice":0.83,"askSize":10000,"bidPrice":0.72,"bidSize":9863,"shortable":3,"etf":0,"ttmEps":-0.444619,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778788800000},"marketStatusCode":2,"adr":0,"listingDate":1740459600000,"exchange":"NASDAQ","adjPreClose":0.7231,"preHourTrading":{"tag":"盘前","latestPrice":0.7726,"preClose":0.7231,"latestTime":"07:16 EDT","volume":52,"amount":37.66039992,"timestamp":1778757361002,"change":0.0495,"changeRate":0.068455,"amplitude":0.000277},"postHourTrading":{"tag":"盘后","latestPrice":0.7232,"preClose":0.7232,"latestTime":"19:17 EDT","volume":11,"amount":7.92,"timestamp":1778714258316,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.965319},"requestUrl":"/m/hq/s/BMGL/wiki","defaultTab":"wiki","newsList":[{"id":"2629952053","title":"Basel Medical Group director Soong Kwek Yoon files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2629952053","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629952053?lang=en_us&edition=fundamental","pubTime":"2026-04-21 23:14","pubTimestamp":1776784465,"startTime":"0","endTime":"0","summary":"Basel Medical Group filed an initial beneficial ownership statement naming Soong Kwek Yoon as a director, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL75B6zc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627393632","title":"Basel Medical Group CFO Lu Jianing files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2627393632","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627393632?lang=en_us&edition=fundamental","pubTime":"2026-04-16 00:24","pubTimestamp":1776270291,"startTime":"0","endTime":"0","summary":"Basel Medical Group disclosed CFO Lu Jianing JN filed an initial Form 3 statement of beneficial ownership dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDLvYdMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627442195","title":"Basel Medical Group files Form 3 for director, Chief Commercial Officer Tan Boon Chye","url":"https://stock-news.laohu8.com/highlight/detail?id=2627442195","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627442195?lang=en_us&edition=fundamental","pubTime":"2026-04-14 22:21","pubTimestamp":1776176495,"startTime":"0","endTime":"0","summary":"Basel Medical Group director, Chief Commercial Officer Tan Boon Chye reported indirect ownership of 10,205,229 ordinary shares in an initial Form 3 dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL72DgWz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627442648","title":"Basel Medical Group director Fung Keng Leong files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2627442648","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627442648?lang=en_us&edition=fundamental","pubTime":"2026-04-14 22:19","pubTimestamp":1776176375,"startTime":"0","endTime":"0","summary":"Basel Medical Group director Fung Keng Leong filed an initial beneficial ownership statement reporting indirect ownership of 10,205,229 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL8VvPsR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311248","title":"Basel Medical appoints CCO Darren Tan to board, replacing Jianing Lu","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311248","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311248?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:11","pubTimestamp":1774869068,"startTime":"0","endTime":"0","summary":"Basel Medical Group appointed Chief Commercial Officer Tan Boon Chye  to its board.Tan replaced Jianing Lu, who resigned as a director on the same day.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL5WTZbs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621661680","title":"Basel Medical Regains Nasdaq Compliance After Amended 2025 Annual Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2621661680","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621661680?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:56","pubTimestamp":1774349779,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd ( ($BMGL) ) has shared an announcement. Basel Medical Group Ltd, a Singapore-based private healthcare group specializing in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/basel-medical-regains-nasdaq-compliance-after-amended-2025-annual-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/basel-medical-regains-nasdaq-compliance-after-amended-2025-annual-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BMGL","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621651550","title":"Nasdaq resolves Basel Medical periodic filing rule deficiency under Listing Rule 5250(c)(1)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621651550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621651550?lang=en_us&edition=fundamental","pubTime":"2026-03-24 18:31","pubTimestamp":1774348264,"startTime":"0","endTime":"0","summary":"Nasdaq notified Basel Medical that it has complied with Listing Rule 5250 after filing an amended annual report on Form 20-F with the SEC.The prior Nasdaq deficiency related to the periodic filing requirement has been resolved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL5pBztB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMGL","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617701569","title":"Basel Medical Group Ltd. Files Initial Beneficial Ownership Statement for Director Paul D. Freudenthaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2617701569","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617701569?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:21","pubTimestamp":1772659268,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd.  filed an initial statement of beneficial ownership reporting Paul D. Freudenthaler as a director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6tvYkc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMGL","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606292489","title":"Basel Medical Group Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2606292489","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606292489?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:37","pubTimestamp":1769413058,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd. has received a notification from Nasdaq stating that the company no longer meets the minimum bid price requirement of $1 per share, as its stock price remained below this threshold for 30 consecutive business days. The company has 180 calendar days to regain compliance, which could involve lifting its share price above $1 for at least ten consecutive business days or potentially implementing a reverse stock split. Failure to resolve the issue may result in delisting from Nasdaq, although an additional 180-day extension could be granted if certain conditions are met. Trading of the company's shares is not currently affected by this non-compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Grou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL3J44Pz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4588","IE00B3QW5Z07.USD","NDAQ","SG9999014039.USD","BK4196","LU2210150020.SGD","BMGL","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","LU0314104364.USD","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014005.SGD","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605286625","title":"Basel Medical Group Receives Nasdaq Delinquency Notice Over Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2605286625","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605286625?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:09","pubTimestamp":1769206168,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd ( ($BMGL) ) just unveiled an announcement. On January 23, 2026, Basel Medical Group Ltd announced it had received a delinqu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/basel-medical-group-receives-nasdaq-delinquency-notice-over-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/basel-medical-group-receives-nasdaq-delinquency-notice-over-minimum-bid-price?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMGL","NQmain","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605285323","title":"Basel Medical receives noncompliance notification from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2605285323","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605285323?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:35","pubTimestamp":1769204123,"startTime":"0","endTime":"0","summary":"Basel Medical (BMGL) announced that it has received notification from Nasdaq that based on the closing bid price of the company’s shares for the la...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/basel-medical-receives-noncompliance-notification-from-nasdaq-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/basel-medical-receives-noncompliance-notification-from-nasdaq-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605285551","title":"Receipt of Delinquency Notification from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2605285551","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605285551?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:30","pubTimestamp":1769203800,"startTime":"0","endTime":"0","summary":"Singapore, Jan.  23, 2026  (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that based on the closing bid price","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/23/3225078/0/en/Receipt-of-Delinquency-Notification-from-Nasdaq.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605408107","title":"Basel Medical Group Acquires Bethesda Medical for $6.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2605408107","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605408107?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:20","pubTimestamp":1769001644,"startTime":"0","endTime":"0","summary":"Basel Medical Group Pte. Ltd., a subsidiary of Basel Medical Group Ltd , has completed the acquisition of all issued and paid-up shares of Bethesda Medical Pte. Ltd., a Singapore-based company, from Silkroute Biomed Healthcare Pte. Ltd. The transaction was completed on April 30, 2025, with a total consideration of US$6.5 million after both parties agreed to waive the previously arranged deferred consideration of US$1.5 million. Bethesda Medical is now a wholly owned indirect subsidiary of Basel Medical Group Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL52hcyH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMGL","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589894873","title":"Basel Medical Group Opens New Orthopaedic Clinic in Novena","url":"https://stock-news.laohu8.com/highlight/detail?id=2589894873","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589894873?lang=en_us&edition=fundamental","pubTime":"2025-12-07 11:43","pubTimestamp":1765078985,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd. has announced the grand opening of its new Singapore Sports & Orthopaedic Clinic - Novena Branch, located at Mount Elizabeth Novena Specialist Centre. This strategic expansion aims to enhance accessibility to specialised orthopaedic and sports-medicine care in Singapore, particularly in the central and northern regions. The new facility offers comprehensive services, including the diagnosis and treatment of musculoskeletal injuries, sports-injury management, joint replacement procedures, and on-site diagnostic imaging. Staffed by an experienced team of orthopaedic surgeons and sports-medicine professionals, the Novena branch supports Basel Medical Group's long-term growth strategy amid rising demand for such services, especially from Singapore's aging population and active communities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-ge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nNDL8CpQLG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588169705","title":"Basel Medical Group Misses Deadline for Annual Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2588169705","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588169705?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:01","pubTimestamp":1764626465,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd. has disclosed a delay in its financial reporting after receiving a Nasdaq notification for not including an auditor's opinion in its annual report on Form 20-F for the fiscal year ended June 30, 2025. The company now has 60 days to submit a compliance plan, with the possibility of an extension of up to 180 days. Trading of its shares on Nasdaq remains unaffected.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL9Ck65z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588705390","title":"Receipt of Delinquency Notification from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2588705390","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588705390?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:30","pubTimestamp":1764624600,"startTime":"0","endTime":"0","summary":"Singapore, Dec.  01, 2025  (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that the Company’s annual report on","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/01/3197483/0/en/Receipt-of-Delinquency-Notification-from-Nasdaq.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMGL","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584939879","title":"Basel Medical Group Ltd. revenue rises 12.6% to S$11.3 million for fiscal 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2584939879","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584939879?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:01","pubTimestamp":1763463660,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd. reported revenue of S$11.3 million  for the fiscal year ended June 30, 2025, an increase of 12.6% from S$10.1 million in the previous year. The revenue growth was mainly due to the acquisition of a general practitioners clinic group, which contributed S$895,362, and a 3.7% increase in revenue from its orthopedic specialist clinic at Gleneagles. Net cash used in operating activities was S$3.4 million, while net cash generated from financing activities totaled S$13.3 million. Cash and cash equivalents at year-end stood at S$3.0 million . The company's directors stated that available working capital is sufficient to meet present requirements for at least 12 months after the period end.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDLbthnn8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578787776","title":"Basel Medical Group Delays Annual Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2578787776","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578787776?lang=en_us&edition=fundamental","pubTime":"2025-10-28 04:05","pubTimestamp":1761595548,"startTime":"0","endTime":"0","summary":"Basel Medical Group Ltd. has announced a delay in filing its Annual Report on Form 20-F for the fiscal year ended June 30, 2025. The company cited the need for additional time to finalize its consolidated financial statements and complete audit procedures, and expects to file the report within fifteen days of the original deadline.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nNDL8dT03X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BMGL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.baselmedical.com","stockEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.3104},{"period":"3month","weight":0.1854},{"period":"6month","weight":-0.4023},{"period":"1year","weight":-0.8393},{"period":"ytd","weight":0.4759}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0819},{"period":"3month","weight":0.0896},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.2649},{"period":"ytd","weight":0.0886}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.","exchange":"NASDAQ","name":"Basel Medical Group Ltd","nameEN":"Basel Medical Group Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Basel Medical Group Ltd(BMGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Basel Medical Group Ltd(BMGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Basel Medical Group Ltd,BMGL,Basel Medical Group Ltd股票,Basel Medical Group Ltd股票老虎,Basel Medical Group Ltd股票老虎国际,Basel Medical Group Ltd行情,Basel Medical Group Ltd股票行情,Basel Medical Group Ltd股价,Basel Medical Group Ltd股市,Basel Medical Group Ltd股票价格,Basel Medical Group Ltd股票交易,Basel Medical Group Ltd股票购买,Basel Medical Group Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Basel Medical Group Ltd(BMGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Basel Medical Group Ltd(BMGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction